Table of Content

1 Vaccine Excipients Market Overview
1.1 Product Overview and Scope of Vaccine Excipients
1.2 Vaccine Excipients Segment by Type
1.2.1 Global Vaccine Excipients Market Value Comparison by Type (2024-2034)
1.2.2 Vaccine Stabilizers
1.2.3 Vaccine Emulsifiers
1.2.4 Vaccine Adjuvants
1.2.5 Preservatives
1.3 Vaccine Excipients Segment by Application
1.3.1 Global Vaccine Excipients Market Value by Application: (2024-2034)
1.3.2 Research Applications
1.3.3 Commercial Applications
1.4 Global Vaccine Excipients Market Size Estimates and Forecasts
1.4.1 Global Vaccine Excipients Revenue 2018-2029
1.4.2 Global Vaccine Excipients Sales 2018-2029
1.4.3 Global Vaccine Excipients Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Vaccine Excipients Market Competition by Manufacturers
2.1 Global Vaccine Excipients Sales Market Share by Manufacturers (2018-2024)
2.2 Global Vaccine Excipients Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Vaccine Excipients Average Price by Manufacturers (2018-2024)
2.4 Global Vaccine Excipients Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Vaccine Excipients, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Vaccine Excipients, Product Type & Application
2.7 Vaccine Excipients Market Competitive Situation and Trends
2.7.1 Vaccine Excipients Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Vaccine Excipients Players Market Share by Revenue
2.7.3 Global Vaccine Excipients Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Vaccine Excipients Retrospective Market Scenario by Region
3.1 Global Vaccine Excipients Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Vaccine Excipients Global Vaccine Excipients Sales by Region: 2018-2029
3.2.1 Global Vaccine Excipients Sales by Region: 2018-2024
3.2.2 Global Vaccine Excipients Sales by Region: 2024-2029
3.3 Global Vaccine Excipients Global Vaccine Excipients Revenue by Region: 2018-2029
3.3.1 Global Vaccine Excipients Revenue by Region: 2018-2024
3.3.2 Global Vaccine Excipients Revenue by Region: 2024-2029
3.4 North America Vaccine Excipients Market Facts & Figures by Country
3.4.1 North America Vaccine Excipients Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Vaccine Excipients Sales by Country (2018-2029)
3.4.3 North America Vaccine Excipients Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Vaccine Excipients Market Facts & Figures by Country
3.5.1 Europe Vaccine Excipients Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Vaccine Excipients Sales by Country (2018-2029)
3.5.3 Europe Vaccine Excipients Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Vaccine Excipients Market Facts & Figures by Country
3.6.1 Asia Pacific Vaccine Excipients Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Vaccine Excipients Sales by Country (2018-2029)
3.6.3 Asia Pacific Vaccine Excipients Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Vaccine Excipients Market Facts & Figures by Country
3.7.1 Latin America Vaccine Excipients Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Vaccine Excipients Sales by Country (2018-2029)
3.7.3 Latin America Vaccine Excipients Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Vaccine Excipients Market Facts & Figures by Country
3.8.1 Middle East and Africa Vaccine Excipients Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Vaccine Excipients Sales by Country (2018-2029)
3.8.3 Middle East and Africa Vaccine Excipients Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Vaccine Excipients Sales by Type (2018-2029)
4.1.1 Global Vaccine Excipients Sales by Type (2018-2024)
4.1.2 Global Vaccine Excipients Sales by Type (2024-2029)
4.1.3 Global Vaccine Excipients Sales Market Share by Type (2018-2029)
4.2 Global Vaccine Excipients Revenue by Type (2018-2029)
4.2.1 Global Vaccine Excipients Revenue by Type (2018-2024)
4.2.2 Global Vaccine Excipients Revenue by Type (2024-2029)
4.2.3 Global Vaccine Excipients Revenue Market Share by Type (2018-2029)
4.3 Global Vaccine Excipients Price by Type (2018-2029)
5 Segment by Application
5.1 Global Vaccine Excipients Sales by Application (2018-2029)
5.1.1 Global Vaccine Excipients Sales by Application (2018-2024)
5.1.2 Global Vaccine Excipients Sales by Application (2024-2029)
5.1.3 Global Vaccine Excipients Sales Market Share by Application (2018-2029)
5.2 Global Vaccine Excipients Revenue by Application (2018-2029)
5.2.1 Global Vaccine Excipients Revenue by Application (2018-2024)
5.2.2 Global Vaccine Excipients Revenue by Application (2024-2029)
5.2.3 Global Vaccine Excipients Revenue Market Share by Application (2018-2029)
5.3 Global Vaccine Excipients Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Curia
6.1.1 Curia Corporation Information
6.1.2 Curia Description and Business Overview
6.1.3 Curia Vaccine Excipients Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Curia Vaccine Excipients Product Portfolio
6.1.5 Curia Recent Developments/Updates
6.2 Croda Pharma
6.2.1 Croda Pharma Corporation Information
6.2.2 Croda Pharma Description and Business Overview
6.2.3 Croda Pharma Vaccine Excipients Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Croda Pharma Vaccine Excipients Product Portfolio
6.2.5 Croda Pharma Recent Developments/Updates
6.3 Alfa Chemistry
6.3.1 Alfa Chemistry Corporation Information
6.3.2 Alfa Chemistry Description and Business Overview
6.3.3 Alfa Chemistry Vaccine Excipients Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Alfa Chemistry Vaccine Excipients Product Portfolio
6.3.5 Alfa Chemistry Recent Developments/Updates
6.4 A & C
6.4.1 A & C Corporation Information
6.4.2 A & C Description and Business Overview
6.4.3 A & C Vaccine Excipients Sales, Revenue and Gross Margin (2018-2024)
6.4.4 A & C Vaccine Excipients Product Portfolio
6.4.5 A & C Recent Developments/Updates
6.5 Avantor
6.5.1 Avantor Corporation Information
6.5.2 Avantor Description and Business Overview
6.5.3 Avantor Vaccine Excipients Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Avantor Vaccine Excipients Product Portfolio
6.5.5 Avantor Recent Developments/Updates
6.6 GS
6.6.1 GS Corporation Information
6.6.2 GS Description and Business Overview
6.6.3 GS Vaccine Excipients Sales, Revenue and Gross Margin (2018-2024)
6.6.4 GS Vaccine Excipients Product Portfolio
6.6.5 GS Recent Developments/Updates
6.7 SEPPIC
6.6.1 SEPPIC Corporation Information
6.6.2 SEPPIC Description and Business Overview
6.6.3 SEPPIC Vaccine Excipients Sales, Revenue and Gross Margin (2018-2024)
6.4.4 SEPPIC Vaccine Excipients Product Portfolio
6.7.5 SEPPIC Recent Developments/Updates
6.8 Novavax
6.8.1 Novavax Corporation Information
6.8.2 Novavax Description and Business Overview
6.8.3 Novavax Vaccine Excipients Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Novavax Vaccine Excipients Product Portfolio
6.8.5 Novavax Recent Developments/Updates
6.9 Dynavax Technologies
6.9.1 Dynavax Technologies Corporation Information
6.9.2 Dynavax Technologies Description and Business Overview
6.9.3 Dynavax Technologies Vaccine Excipients Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Dynavax Technologies Vaccine Excipients Product Portfolio
6.9.5 Dynavax Technologies Recent Developments/Updates
6.10 Sanofi
6.10.1 Sanofi Corporation Information
6.10.2 Sanofi Description and Business Overview
6.10.3 Sanofi Vaccine Excipients Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Sanofi Vaccine Excipients Product Portfolio
6.10.5 Sanofi Recent Developments/Updates
6.11 Zhifei Biological
6.11.1 Zhifei Biological Corporation Information
6.11.2 Zhifei Biological Vaccine Excipients Description and Business Overview
6.11.3 Zhifei Biological Vaccine Excipients Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Zhifei Biological Vaccine Excipients Product Portfolio
6.11.5 Zhifei Biological Recent Developments/Updates
6.12 Escon
6.12.1 Escon Corporation Information
6.12.2 Escon Vaccine Excipients Description and Business Overview
6.12.3 Escon Vaccine Excipients Sales, Revenue and Gross Margin (2018-2024)
6.12.4 Escon Vaccine Excipients Product Portfolio
6.12.5 Escon Recent Developments/Updates
6.13 Rico Bio
6.13.1 Rico Bio Corporation Information
6.13.2 Rico Bio Vaccine Excipients Description and Business Overview
6.13.3 Rico Bio Vaccine Excipients Sales, Revenue and Gross Margin (2018-2024)
6.13.4 Rico Bio Vaccine Excipients Product Portfolio
6.13.5 Rico Bio Recent Developments/Updates
6.14 CSL Limited
6.14.1 CSL Limited Corporation Information
6.14.2 CSL Limited Vaccine Excipients Description and Business Overview
6.14.3 CSL Limited Vaccine Excipients Sales, Revenue and Gross Margin (2018-2024)
6.14.4 CSL Limited Vaccine Excipients Product Portfolio
6.14.5 CSL Limited Recent Developments/Updates
6.15 Creative Biolabs
6.15.1 Creative Biolabs Corporation Information
6.15.2 Creative Biolabs Vaccine Excipients Description and Business Overview
6.15.3 Creative Biolabs Vaccine Excipients Sales, Revenue and Gross Margin (2018-2024)
6.15.4 Creative Biolabs Vaccine Excipients Product Portfolio
6.15.5 Creative Biolabs Recent Developments/Updates
6.16 Central Drug House
6.16.1 Central Drug House Corporation Information
6.16.2 Central Drug House Vaccine Excipients Description and Business Overview
6.16.3 Central Drug House Vaccine Excipients Sales, Revenue and Gross Margin (2018-2024)
6.16.4 Central Drug House Vaccine Excipients Product Portfolio
6.16.5 Central Drug House Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Vaccine Excipients Industry Chain Analysis
7.2 Vaccine Excipients Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Vaccine Excipients Production Mode & Process
7.4 Vaccine Excipients Sales and Marketing
7.4.1 Vaccine Excipients Sales Channels
7.4.2 Vaccine Excipients Distributors
7.5 Vaccine Excipients Customers
8 Vaccine Excipients Market Dynamics
8.1 Vaccine Excipients Industry Trends
8.2 Vaccine Excipients Market Drivers
8.3 Vaccine Excipients Market Challenges
8.4 Vaccine Excipients Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Vaccine Excipients Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Vaccine Excipients Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Vaccine Excipients Market Competitive Situation by Manufacturers in 2022
Table 4. Global Vaccine Excipients Sales (kg) of Key Manufacturers (2018-2024)
Table 5. Global Vaccine Excipients Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Vaccine Excipients Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Vaccine Excipients Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Vaccine Excipients Average Price (US$/g) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Vaccine Excipients, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Vaccine Excipients, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Vaccine Excipients, Product Type & Application
Table 12. Global Key Manufacturers of Vaccine Excipients, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Vaccine Excipients by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccine Excipients as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Vaccine Excipients Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Vaccine Excipients Sales by Region (2018-2024) & (kg)
Table 18. Global Vaccine Excipients Sales Market Share by Region (2018-2024)
Table 19. Global Vaccine Excipients Sales by Region (2024-2029) & (kg)
Table 20. Global Vaccine Excipients Sales Market Share by Region (2024-2029)
Table 21. Global Vaccine Excipients Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Vaccine Excipients Revenue Market Share by Region (2018-2024)
Table 23. Global Vaccine Excipients Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Vaccine Excipients Revenue Market Share by Region (2024-2029)
Table 25. North America Vaccine Excipients Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Vaccine Excipients Sales by Country (2018-2024) & (kg)
Table 27. North America Vaccine Excipients Sales by Country (2024-2029) & (kg)
Table 28. North America Vaccine Excipients Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Vaccine Excipients Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Vaccine Excipients Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Vaccine Excipients Sales by Country (2018-2024) & (kg)
Table 32. Europe Vaccine Excipients Sales by Country (2024-2029) & (kg)
Table 33. Europe Vaccine Excipients Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Vaccine Excipients Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Vaccine Excipients Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Vaccine Excipients Sales by Region (2018-2024) & (kg)
Table 37. Asia Pacific Vaccine Excipients Sales by Region (2024-2029) & (kg)
Table 38. Asia Pacific Vaccine Excipients Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Vaccine Excipients Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Vaccine Excipients Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Vaccine Excipients Sales by Country (2018-2024) & (kg)
Table 42. Latin America Vaccine Excipients Sales by Country (2024-2029) & (kg)
Table 43. Latin America Vaccine Excipients Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Vaccine Excipients Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Vaccine Excipients Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Vaccine Excipients Sales by Country (2018-2024) & (kg)
Table 47. Middle East & Africa Vaccine Excipients Sales by Country (2024-2029) & (kg)
Table 48. Middle East & Africa Vaccine Excipients Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Vaccine Excipients Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Vaccine Excipients Sales (kg) by Type (2018-2024)
Table 51. Global Vaccine Excipients Sales (kg) by Type (2024-2029)
Table 52. Global Vaccine Excipients Sales Market Share by Type (2018-2024)
Table 53. Global Vaccine Excipients Sales Market Share by Type (2024-2029)
Table 54. Global Vaccine Excipients Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Vaccine Excipients Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Vaccine Excipients Revenue Market Share by Type (2018-2024)
Table 57. Global Vaccine Excipients Revenue Market Share by Type (2024-2029)
Table 58. Global Vaccine Excipients Price (US$/g) by Type (2018-2024)
Table 59. Global Vaccine Excipients Price (US$/g) by Type (2024-2029)
Table 60. Global Vaccine Excipients Sales (kg) by Application (2018-2024)
Table 61. Global Vaccine Excipients Sales (kg) by Application (2024-2029)
Table 62. Global Vaccine Excipients Sales Market Share by Application (2018-2024)
Table 63. Global Vaccine Excipients Sales Market Share by Application (2024-2029)
Table 64. Global Vaccine Excipients Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Vaccine Excipients Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Vaccine Excipients Revenue Market Share by Application (2018-2024)
Table 67. Global Vaccine Excipients Revenue Market Share by Application (2024-2029)
Table 68. Global Vaccine Excipients Price (US$/g) by Application (2018-2024)
Table 69. Global Vaccine Excipients Price (US$/g) by Application (2024-2029)
Table 70. Curia Corporation Information
Table 71. Curia Description and Business Overview
Table 72. Curia Vaccine Excipients Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2018-2024)
Table 73. Curia Vaccine Excipients Product
Table 74. Curia Recent Developments/Updates
Table 75. Croda Pharma Corporation Information
Table 76. Croda Pharma Description and Business Overview
Table 77. Croda Pharma Vaccine Excipients Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2018-2024)
Table 78. Croda Pharma Vaccine Excipients Product
Table 79. Croda Pharma Recent Developments/Updates
Table 80. Alfa Chemistry Corporation Information
Table 81. Alfa Chemistry Description and Business Overview
Table 82. Alfa Chemistry Vaccine Excipients Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2018-2024)
Table 83. Alfa Chemistry Vaccine Excipients Product
Table 84. Alfa Chemistry Recent Developments/Updates
Table 85. A & C Corporation Information
Table 86. A & C Description and Business Overview
Table 87. A & C Vaccine Excipients Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2018-2024)
Table 88. A & C Vaccine Excipients Product
Table 89. A & C Recent Developments/Updates
Table 90. Avantor Corporation Information
Table 91. Avantor Description and Business Overview
Table 92. Avantor Vaccine Excipients Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2018-2024)
Table 93. Avantor Vaccine Excipients Product
Table 94. Avantor Recent Developments/Updates
Table 95. GS Corporation Information
Table 96. GS Description and Business Overview
Table 97. GS Vaccine Excipients Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2018-2024)
Table 98. GS Vaccine Excipients Product
Table 99. GS Recent Developments/Updates
Table 100. SEPPIC Corporation Information
Table 101. SEPPIC Description and Business Overview
Table 102. SEPPIC Vaccine Excipients Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2018-2024)
Table 103. SEPPIC Vaccine Excipients Product
Table 104. SEPPIC Recent Developments/Updates
Table 105. Novavax Corporation Information
Table 106. Novavax Description and Business Overview
Table 107. Novavax Vaccine Excipients Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2018-2024)
Table 108. Novavax Vaccine Excipients Product
Table 109. Novavax Recent Developments/Updates
Table 110. Dynavax Technologies Corporation Information
Table 111. Dynavax Technologies Description and Business Overview
Table 112. Dynavax Technologies Vaccine Excipients Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2018-2024)
Table 113. Dynavax Technologies Vaccine Excipients Product
Table 114. Dynavax Technologies Recent Developments/Updates
Table 115. Sanofi Corporation Information
Table 116. Sanofi Description and Business Overview
Table 117. Sanofi Vaccine Excipients Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2018-2024)
Table 118. Sanofi Vaccine Excipients Product
Table 119. Sanofi Recent Developments/Updates
Table 120. Zhifei Biological Corporation Information
Table 121. Zhifei Biological Description and Business Overview
Table 122. Zhifei Biological Vaccine Excipients Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2018-2024)
Table 123. Zhifei Biological Vaccine Excipients Product
Table 124. Zhifei Biological Recent Developments/Updates
Table 125. Escon Corporation Information
Table 126. Escon Description and Business Overview
Table 127. Escon Vaccine Excipients Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2018-2024)
Table 128. Escon Vaccine Excipients Product
Table 129. Escon Recent Developments/Updates
Table 130. Rico Bio Corporation Information
Table 131. Rico Bio Description and Business Overview
Table 132. Rico Bio Vaccine Excipients Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2018-2024)
Table 133. Rico Bio Vaccine Excipients Product
Table 134. Rico Bio Recent Developments/Updates
Table 135. CSL Limited Corporation Information
Table 136. CSL Limited Description and Business Overview
Table 137. CSL Limited Vaccine Excipients Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2018-2024)
Table 138. CSL Limited Vaccine Excipients Product
Table 139. CSL Limited Recent Developments/Updates
Table 140. Creative Biolabs Corporation Information
Table 141. Creative Biolabs Description and Business Overview
Table 142. Creative Biolabs Vaccine Excipients Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2018-2024)
Table 143. Creative Biolabs Vaccine Excipients Product
Table 144. Creative Biolabs Recent Developments/Updates
Table 145. Central Drug House Corporation Information
Table 146. Central Drug House Description and Business Overview
Table 147. Central Drug House Vaccine Excipients Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2018-2024)
Table 148. Central Drug House Vaccine Excipients Product
Table 149. Central Drug House Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Vaccine Excipients Distributors List
Table 153. Vaccine Excipients Customers List
Table 154. Vaccine Excipients Market Trends
Table 155. Vaccine Excipients Market Drivers
Table 156. Vaccine Excipients Market Challenges
Table 157. Vaccine Excipients Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Vaccine Excipients
Figure 2. Global Vaccine Excipients Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Vaccine Excipients Market Share by Type in 2022 & 2029
Figure 4. Vaccine Stabilizers Product Picture
Figure 5. Vaccine Emulsifiers Product Picture
Figure 6. Vaccine Adjuvants Product Picture
Figure 7. Preservatives Product Picture
Figure 8. Global Vaccine Excipients Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 9. Global Vaccine Excipients Market Share by Application in 2022 & 2029
Figure 10. Research Applications
Figure 11. Commercial Applications
Figure 12. Global Vaccine Excipients Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Vaccine Excipients Market Size (2018-2029) & (US$ Million)
Figure 14. Global Vaccine Excipients Sales (2018-2029) & (kg)
Figure 15. Global Vaccine Excipients Average Price (US$/g) & (2018-2029)
Figure 16. Vaccine Excipients Report Years Considered
Figure 17. Vaccine Excipients Sales Share by Manufacturers in 2022
Figure 18. Global Vaccine Excipients Revenue Share by Manufacturers in 2022
Figure 19. The Global 5 and 10 Largest Vaccine Excipients Players: Market Share by Revenue in 2022
Figure 20. Vaccine Excipients Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 21. Global Vaccine Excipients Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 22. North America Vaccine Excipients Sales Market Share by Country (2018-2029)
Figure 23. North America Vaccine Excipients Revenue Market Share by Country (2018-2029)
Figure 24. United States Vaccine Excipients Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Canada Vaccine Excipients Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Europe Vaccine Excipients Sales Market Share by Country (2018-2029)
Figure 27. Europe Vaccine Excipients Revenue Market Share by Country (2018-2029)
Figure 28. Germany Vaccine Excipients Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. France Vaccine Excipients Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. U.K. Vaccine Excipients Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Italy Vaccine Excipients Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Russia Vaccine Excipients Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Asia Pacific Vaccine Excipients Sales Market Share by Region (2018-2029)
Figure 34. Asia Pacific Vaccine Excipients Revenue Market Share by Region (2018-2029)
Figure 35. China Vaccine Excipients Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Japan Vaccine Excipients Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. South Korea Vaccine Excipients Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. India Vaccine Excipients Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Australia Vaccine Excipients Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. China Taiwan Vaccine Excipients Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Southeast Asia Vaccine Excipients Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Latin America Vaccine Excipients Sales Market Share by Country (2018-2029)
Figure 43. Latin America Vaccine Excipients Revenue Market Share by Country (2018-2029)
Figure 44. Mexico Vaccine Excipients Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Brazil Vaccine Excipients Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Argentina Vaccine Excipients Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Vaccine Excipients Sales Market Share by Country (2018-2029)
Figure 48. Middle East & Africa Vaccine Excipients Revenue Market Share by Country (2018-2029)
Figure 49. Turkey Vaccine Excipients Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia Vaccine Excipients Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. UAE Vaccine Excipients Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Global Sales Market Share of Vaccine Excipients by Type (2018-2029)
Figure 53. Global Revenue Market Share of Vaccine Excipients by Type (2018-2029)
Figure 54. Global Vaccine Excipients Price (US$/g) by Type (2018-2029)
Figure 55. Global Sales Market Share of Vaccine Excipients by Application (2018-2029)
Figure 56. Global Revenue Market Share of Vaccine Excipients by Application (2018-2029)
Figure 57. Global Vaccine Excipients Price (US$/g) by Application (2018-2029)
Figure 58. Vaccine Excipients Value Chain
Figure 59. Vaccine Excipients Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed